This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by North, K. Search for Related Content PubMed PubMed Citation Articles by North, K. Social Bookmarking                   What's this?

Neurofibromatosis Type 1: Review of the First 200 Patients in an Australian Clinic

Department of Neurology, The Children's Hospital, Camperdown, Sydney, Australia

Neurofibromatosis type 1 is a common multisystem disorder, best managed in a multidisciplinary clinic. In 1991, the first Australian neurofibromatosis clinic was established at the Children's Hospital, Camperdown, and the clinical characteristics of the first 150 families are reviewed.

Two hundred individuals were assessed; there was an equal sex distribution, and 55% of cases were sporadic. Advanced paternal age appeared to predispose to new mutations in the neurofibromatosis gene. Café-au-lait spots and axillary freckling were important to the diagnosis of neurofibromatosis type 1 during childhood, and neurofibromas and Lisch nodules, although often not appearing until after puberty, were present in almost all patients over 30 years of age. Short stature (27%), macrocephaly (43%), scoliosis (20.5%), and learning disabilities (45%) were common associated features. The prevalence of disease complications was similar to the major US and European studies. (J Child Neurol 1993;8:395-402).

Journal of Child Neurology, Vol. 8, No. 4, 395-402 (1993)
DOI: 10.1177/088307389300800421


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				H. Chen, Y. Qiu, L. Chen, L. Li, J. Chen, C. Zhang, B. Wang, Y. Yu, Z. Zhu, F. Zhu, et al. The Expression of Neurofibromin in Human Osteoblasts and Chondrocytes Ann. Clin. Lab. Sci., January 1, 2008; 38(1): 25 - 30. [Abstract] [Full Text] [PDF]

				A. Devlin Paediatric neurological examination Advan. Psychiatr. Treat., March 1, 2003; 9(2): 125 - 134. [Abstract] [Full Text] [PDF]

				T. Rosser and R. J. Packer Review Article : Neurofibromas in Children With Neurofibromatosis 1 J Child Neurol, August 1, 2002; 17(8): 585 - 591. [Abstract] [PDF]

				R. M. Costa and A. J. Silva Review Article : Molecular and Cellular Mechanisms Underlying the Cognitive Deficits Associated With Neurofibromatosis 1 J Child Neurol, August 1, 2002; 17(8): 622 - 626. [Abstract] [PDF]

				M POYHONEN A clinical assessment of neurofibromatosis type 1 (NF1) and segmental NF in northern Finland J. Med. Genet., December 1, 2000; 37(12): 43e - 43. [Full Text]

				K. DeBella, J. Szudek, and J. M. Friedman Use of the National Institutes of Health Criteria for Diagnosis of Neurofibromatosis 1 in Children Pediatrics, March 1, 2000; 105(3): 608 - 614. [Abstract] [Full Text]

				D. Carmi, M. Shohat, A. Metzker, and Z. Dickerman Growth, Puberty, and Endocrine Functions in Patients With Sporadic or Familial Neurofibromatosis Type 1: A Longitudinal Study Pediatrics, June 1, 1999; 103(6): 1257 - 1262. [Abstract] [Full Text]

				D. H. Gutmann, A. Aylsworth, J. C. Carey, B. Korf, J. Marks, R. E. Pyeritz, A. Rubenstein, and D. Viskochil The Diagnostic Evaluation and Multidisciplinary Management of Neurofibromatosis 1 and Neurofibromatosis 2 JAMA, July 2, 1997; 278(1): 51 - 57. [Abstract] [PDF]

				A. Zvulunov, Y. Barak, and A. Metzker Juvenile Xanthogranuloma, Neurofibromatosis, and Juvenile Chronic Myelogenous Leukemia: World Statistical Analysis Arch Dermatol, August 1, 1995; 131(8): 904 - 908. [Abstract] [PDF]